Literature DB >> 22211765

Combinational sensitization of Leishmania with uroporphyrin and aluminum phthalocyanine synergistically enhances their photodynamic inactivation in vitro and in vivo.

Sujoy Dutta1, Kayoko Waki, Kwang Poo Chang.   

Abstract

Leishmania were previously shown to undergo photolysis when their transgenic mutants were induced endogenously to accumulate cytoplasmic uroporphyrin or when loaded exogenously with aluminum phthalocyanine chloride. A combinational use of both is reported here, which renders Leishmania far more susceptible to photolysis. Fluorescence microscopy of cells loaded with the two photosensitizers localized them to different subcellular sites. Pre-exposure of Leishmania to both synergistically sensitized them for photolysis as extracellular promastigotes and intracellular amastigotes in infected macrophages in vitro when illuminated at specific wavelengths to excite the respective photosensitizers for production of reactive oxygen species. Both Leishmania stages lost their viability completely when doubly photosensitized optimally and illuminated at low intensity, the host cells being left unscathed. Inoculation of mice with photoinactivated Leishmania produced no lesions, which invariably developed in the control groups during a period of observations for 8 weeks. Pretreatment of Leishmania with both photosensitizers rendered these cells susceptible to clearance from the ear dermis by white light illumination. The results suggest that double photosensitization for synergistic activity enhances the efficacy and safety of photodynamic therapy in general and for Leishmania in particular.
© 2012 Wiley Periodicals, Inc. Photochemistry and Photobiology © 2012 The American Society of Photobiology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22211765      PMCID: PMC3337340          DOI: 10.1111/j.1751-1097.2012.01076.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  14 in total

Review 1.  Molecular determinants of Leishmania virulence.

Authors:  K P Chang; G Chaudhuri; D Fong
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

Review 2.  Molecular basis for therapy resistance.

Authors:  Per E Lønning
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

Review 3.  The photobiology of photodynamic therapy: cellular targets and mechanisms.

Authors:  N L Oleinick; H H Evans
Journal:  Radiat Res       Date:  1998-11       Impact factor: 2.841

4.  Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro.

Authors:  Sujoy Dutta; Debalina Ray; Bala K Kolli; Kwang-Poo Chang
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

Review 5.  Recent advances in the prevention and treatment of skin cancer using photodynamic therapy.

Authors:  Baozhong Zhao; Yu-Ying He
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

6.  Leishmania spp.: delta-aminolevulinate-inducible neogenesis of porphyria by genetic complementation of incomplete heme biosynthesis pathway.

Authors:  Sujoy Dutta; Kazumichi Furuyama; Shigeru Sassa; Kwang-Poo Chang
Journal:  Exp Parasitol       Date:  2007-12-03       Impact factor: 2.011

7.  The synergistic effects of rhodamine-123 and merocyanine-540 laser dyes on human tumor cell lines: a new approach to laser phototherapy.

Authors:  D J Castro; R E Saxton; S Haghighat; E Reisler; D Plant; J Soudant
Journal:  Otolaryngol Head Neck Surg       Date:  1993-03       Impact factor: 3.497

8.  Transgenic Leishmania model for delta-aminolevulinate-inducible monospecific uroporphyria: cytolytic phototoxicity initiated by singlet oxygen-mediated inactivation of proteins and its ablation by endosomal mobilization of cytosolic uroporphyrin.

Authors:  Sujoy Dutta; Bala Krishna Kolli; Aihua Tang; Shigeru Sassa; Kwang-Poo Chang
Journal:  Eukaryot Cell       Date:  2008-05-16

9.  Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors.

Authors:  G Canti; D Lattuada; S Morelli; A Nicolin; R Cubeddu; P Taroni; G Valentini
Journal:  Cancer Lett       Date:  1995-07-13       Impact factor: 8.679

10.  Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine.

Authors:  Sujoy Dutta; Benson G Ongarora; Hairong Li; Maria da Graca H Vicente; Bala K Kolli; Kwang Poo Chang
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

View more
  10 in total

1.  In vitro evaluation of photodynamic therapy using curcumin on Leishmania major and Leishmania braziliensis.

Authors:  Juliana Guerra Pinto; Letícia Correa Fontana; Marco Antonio de Oliveira; Cristina Kurachi; Leandro José Raniero; Juliana Ferreira-Strixino
Journal:  Lasers Med Sci       Date:  2016-04-07       Impact factor: 3.161

Review 2.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

3.  Photodynamic Therapy With Bengal Rose and Derivatives Against Leishmania amazonensis.

Authors:  Taisa Rocha Navasconi; Vanessa Nesi Dos Reis; Camila Fabiano Freitas; Paulo Cesar de Souza Pereira; Wilker Caetano; Noboru Hioka; Maria Valdrinez Campana Lonardoni; Sandra Mara Alessi Aristides; Thaís Gomes Verzignassi Silveira
Journal:  J Lasers Med Sci       Date:  2017-01-08

4.  Aminophthalocyanine-Mediated Photodynamic Inactivation of Leishmania tropica.

Authors:  Ahmed Al-Qahtani; Saad Alkahtani; Bala Kolli; Pankaj Tripathi; Sujoy Dutta; Abdullah A Al-Kahtane; Xiong-Jie Jiang; Dennis K P Ng; Kwang Poo Chang
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 5.  New "light" for one-world approach toward safe and effective control of animal diseases and insect vectors from leishmaniac perspectives.

Authors:  Kwang Poo Chang; Bala K Kolli
Journal:  Parasit Vectors       Date:  2016-07-13       Impact factor: 3.876

6.  Vaccination for Disease Prevention and Control: the Necessity of Renewed Emphasis and New Approaches.

Authors:  Kwang Poo Chang
Journal:  J Immunol Immunotech       Date:  2014-07-09

7.  Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis.

Authors:  Sayonara M Viana; Fabiana S Celes; Laura Ramirez; Bala Kolli; Dennis K P Ng; Kwang P Chang; Camila I de Oliveira
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

Review 8.  Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?

Authors:  Kwang Poo Chang; Joseph M Reynolds; Ying Liu; Johnny J He
Journal:  Vaccines (Basel)       Date:  2022-02-07

9.  Nanoemulsions with Chloroaluminium Phthalocyanine and Paromomycin for Combined Photodynamic and Antibiotic Therapy for Cutaneous Leishmaniasis.

Authors:  Sandra Milena Leal Pinto; Luis Alexandre Muehlmann; Lucía Liliana Mantilla Ojeda; Angélica María Vera Arias; Martha Viviana Roa Cordero; María de Fátima Menezes Almeida Santos; Ricardo Bentes Azevedo; Patricia Escobar Rivero
Journal:  Infect Chemother       Date:  2021-06

10.  Photodynamic inactivation of Leishmania braziliensis doubly sensitized with uroporphyrin and diamino-phthalocyanine activates effector functions of macrophages in vitro.

Authors:  Rohit Sharma; Sayonara M Viana; Dennis K P Ng; Bala K Kolli; Kwang Poo Chang; Camila I de Oliveira
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.